Community-engaged development and testing of virtual peer groups to increase technology use among Latinx adolescents with type 1 diabetes and their caregivers
5 affiliations
- 1University of California Davis School of Medicine, Sacramento, CA, United States of America
- 2University of California San Francisco, San Francisco, CA, United States of America
- 3Children’s Hospital Los Angeles, Los Angeles, CA, United States of America
- 4Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America
- 5Oregon Health & Science University, Portland, OR, United States of America
Abstract
Latinx adolescents with type 1 diabetes (T1D) have lower diabetes technology use and less optimal health outcomes compared to non-marginalized populations. In keeping with the tenants of social cognitive theory, adolescents with T1D who participate in virtual peer groups (VPGs) experience improved outcomes and technology use, but VPGs have not been developed or tested specifically in a Latinx cohort. Our previous focus groups with Latinx adolescents and caregivers revealed an urgent need for community-building, support, and culturally relevant information on multiple T1D topics, including diabetes technology. Through a community-engaged research process we developed a VPG intervention - Device use Reimagined through Education And Mentorship (DREAM) - for Latinx adolescents with T1D and their caregivers, and designed a pragmatic trial to assess the impact of this intervention. VPG content was created for both age groups and in two languages through an iterative approach with input from a multi-site community advisory council. VPG sessions covered six topics within T1D self-care, and were delivered to participants over 6-12 months. VPG facilitator recruitment prioritized linguistic and cultural congruence with participants as well as personal or professional experience with T1D. Clinical trial design was heavily influenced by stakeholder input which prioritized opportunities for community-building outside of the clinical environment. The resulting clinical trial will yield important information about how to engage a historically underrepresented group in clinical research, and build essential knowledge about the utility of VPG interventions to narrow existing disparities in T1D care.
Related
- A Taxonomy of Mental Health and Technology Needs for Alzheimer’s and Dementia Caregivers
- Support Groups for Caregivers of Adolescents With HIV - A Qualitative Analysis of Caregivers’ Experiences in Mozambique
- The lived experiences of primary caregivers supporting adolescents with non-suicidal self-injury: a qualitative systematic review and meta-aggregation
- Which changes in adolescents' knowledge, attitudes, and practices following a school-based intervention in France increase HPV vaccination uptake and intentions? A mediation analysis
- Dual-theoretical framework integrating the stress process model and family systems theory-based psychological intervention for caregivers of children and adolescents with mood disorders: study protocol for a randomized controlled trial
BibTeX
@article{crossen2026communityengaged,
title = {{Community-engaged development and testing of virtual peer groups to increase technology use among Latinx adolescents with type 1 diabetes and their caregivers}},
author = {Stephanie S. Crossen and Jenise C. Wong and Jaquelin Flores Garcia and Mark W. Reid and Alejandra Torres Sanchez and Brenda Manzanarez and Frances Gonzalez and Natalia Garban and Salvador Lopez and Marysol Gonzales Granados and Cristina Acosta Navarro and Alfredo Lopez Aguirre and Jill Weissberg-Benchell and Michael A. Harris and Jennifer K. Raymond},
journal = {Contemporary clinical trials},
year = {2026},
month = aug,
doi = {10.1016/j.cct.2026.108435},
url = {https://doi.org/10.1016/j.cct.2026.108435},
note = {CC BY},
}
RIS
TY - JOUR
TI - Community-engaged development and testing of virtual peer groups to increase technology use among Latinx adolescents with type 1 diabetes and their caregivers
AU - Stephanie S. Crossen
AU - Jenise C. Wong
AU - Jaquelin Flores Garcia
AU - Mark W. Reid
AU - Alejandra Torres Sanchez
AU - Brenda Manzanarez
AU - Frances Gonzalez
AU - Natalia Garban
AU - Salvador Lopez
AU - Marysol Gonzales Granados
AU - Cristina Acosta Navarro
AU - Alfredo Lopez Aguirre
AU - Jill Weissberg-Benchell
AU - Michael A. Harris
AU - Jennifer K. Raymond
PY - 2026
DA - 2026/08/11
JO - Contemporary clinical trials
DO - 10.1016/j.cct.2026.108435
UR - https://doi.org/10.1016/j.cct.2026.108435
AB - Latinx adolescents with type 1 diabetes (T1D) have lower diabetes technology use and less optimal health outcomes compared to non-marginalized populations. In keeping with the tenants of social cognitive theory, adolescents with T1D who participate in virtual peer groups (VPGs) experience improved outcomes and technology use, but VPGs have not been developed or tested specifically in a Latinx cohort. Our previous focus groups with Latinx adolescents and caregivers revealed an urgent need for community-building, support, and culturally relevant information on multiple T1D topics, including diabetes technology. Through a community-engaged research process we developed a VPG intervention - Device use Reimagined through Education And Mentorship (DREAM) - for Latinx adolescents with T1D and their caregivers, and designed a pragmatic trial to assess the impact of this intervention. VPG content was created for both age groups and in two languages through an iterative approach with input from a multi-site community advisory council. VPG sessions covered six topics within T1D self-care, and were delivered to participants over 6-12 months. VPG facilitator recruitment prioritized linguistic and cultural congruence with participants as well as personal or professional experience with T1D. Clinical trial design was heavily influenced by stakeholder input which prioritized opportunities for community-building outside of the clinical environment. The resulting clinical trial will yield important information about how to engage a historically underrepresented group in clinical research, and build essential knowledge about the utility of VPG interventions to narrow existing disparities in T1D care.
SN - 1551-7144
SN - 1559-2030
ER -